High Tide Inc. filed its unaudited interim financial statements and management discussion & analysis for the three and nine months ended July 31, 2026. Revenue increased 33% year-over-year to $198.8 million CAD in Q3, driven by a $38.2 million contribution from the medical cannabis distribution segment acquired via Remexian and organic growth in its bricks-and-mortar retail operations. Gross profit rose 32% to $52.7 million CAD with margins stable at 27%. Adjusted EBITDA grew 53% to $16.2 million CAD, yielding an 8% margin. Net income was $12.7 million CAD compared to a loss in the prior year period. The company operates as Canada's largest cannabis retail chain and distributes medical cannabis in Germany.
